Victory Capital Management Inc 9 Meters Biopharma, Inc. Transaction History

Victory Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$0.26 - $0.64 $59 - $145	227 Added 0.66%	34,578 $9,000
Q1 2022 May 04, 2022	SELL	$0.52 - $1.0 $897 - $1,725	-1,725 Reduced 4.78%	34,351 $14,000
Q4 2021 Feb 07, 2022	SELL	$0.85 - $1.33 $840 - $1,315	-989 Reduced 2.67%	36,076 $35,000
Q3 2021 Nov 02, 2021	SELL	$1.03 - $1.41 $1,398 - $1,914	-1,358 Reduced 3.53%	37,065 $48,000
Q2 2021 Aug 03, 2021	BUY	$1.04 - $1.5 $6,970 - $10,053	6,702 Added 21.13%	38,423 $42,000
Q1 2021 May 04, 2021	BUY	$0.84 - $2.16 $204 - $524	243 Added 0.77%	31,721 $37,000
Q4 2020 Feb 01, 2021	BUY	$0.65 - $1.11 $6,823 - $11,652	10,498 Added 50.04%	31,478 $27,000
Q3 2020 Nov 09, 2020	BUY	$0.48 - $0.84 $3,002 - $5,254	6,255 Added 42.48%	20,980 $17,000
Q2 2020 Aug 07, 2020	BUY	$0.43 - $0.74 $6,331 - $10,896	14,725 New	14,725 $8,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.